Novartis has long been committed to understanding sickle cell disease and working towards treatment. Together, we can do more.
Learn how Novartis is pushing the boundaries with bold science, seeking to transform lives and striving toward cures for patients.
Join us for a ‘hard core’ science event focused on finding therapeutic solutions to this ongoing health crisis.
Novartis is responding to the coronavirus disease (COVID-19) outbreak. The information center provides a central hub for news, guidance and resources.
Living with sickle cell disease has many challenges. At Novartis, we work to improve outcomes and provide hope for… https://t.co/edOdPS255P
We are recognized with the GlobalCapital Bond Awards 2021 for the Most Impressive Corporate Sustainability-Linked B… https://t.co/ah9wI3Dvod
‘We support the manufacturing of COVID-19 vaccines at various stages of the process and in multiple production site… https://t.co/zYUr6vfN26
Investing in innovative treatments is vital to alleviate the suffering caused by multiple sclerosis (MS).
Jordan, a melanoma survivor, shares her experience with melanoma, BRAF mutation testing and the importance of patient empowerment.
From dyes and chemicals to breakthrough innovation. Although only 25 years young, Novartis has a rich company history that roots back more than 250 years.
This site is intended for a global audience.